Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CHRM2 | P08172 | 1/20 | 0.33 |
| ▸ | PIK3CD | O00329 | 1/20 | 0.33 |
| ▸ | MEN1 | O00255 | 1/20 | 0.32 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.32 |
| ▸ | DDAH1 | O94760 | 1/20 | 0.32 |
| ▸ | LCK | P06239 | 1/20 | 0.32 |
| ▸ | ODC1 | P11926 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL32679310 | 0.90 | CHRM2 (0.33) | CHRM2DDAH1LCKODC1 | |
| SCHEMBL14075564 | 0.90 | CHRM2 (0.33) | CHRM2DDAH1LCKODC1 | |
| SCHEMBL10820636 | 0.89 | DDAH1 (0.32) | DDAH1 | |
| SCHEMBL31614498 | 0.87 | CA2 (0.33) | — | |
| SCHEMBL24899453 | 0.87 | CA2 (0.33) | — | |
| SCHEMBL8309353 | 0.84 | PIK3CD (0.36) | PIK3CDMEN1KMT2ALCK | |
| Hydrochloric Acid SCHEMBL27224865 | 0.82 | PIK3CD (0.34) | PIK3CDMEN1KMT2ALCK | |
| SCHEMBL20036528 | 0.82 | TDP1 (0.39) | MEN1KMT2ADDAH1 | |
| SCHEMBL13925694 | 0.81 | PIK3CD (0.37) | PIK3CDMEN1KMT2A | |
| SCHEMBL1292539 | 0.81 | PIK3CD (0.43) | PIK3CDMEN1KMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-118556115-A | Surface treatment agent, material to be treated having coating film, and method for producing same | 日本帕卡濑精株式会社 | 2024-08-27 | — | — | CN | disclosed |
| WO-2023071601-A1 | DESLORATADINE DERIVATIVE, PREPARATION METHOD THEREFOR AND APPLICATION THEREOF | 天津市昕晨投资发展有限公司 | 2023-05-04 | — | — | WO | disclosed |
| CN-111936558-B | Polysiloxane compounds and compositions | 日本帕卡濑精株式会社 | 2022-03-18 | — | — | CN | disclosed |
| EP-1450774-A4 | CHLORIN PHOTOSENSITIZING AGENTS FOR USE IN PHOTODYNAMIC THERAPY | MIRAVANT PHARM INC (US) | 2005-10-26 | — | — | EP | disclosed |
| US-20050020559-A1 | Chlorin photosensitizing agents for use in photodynamic therapy | MIRAVANT PHARMACEUTICALS, INC., | 2005-01-27 | — | — | US | disclosed |
| EP-1450774-A2 | CHLORIN PHOTOSENSITIZING AGENTS FOR USE IN PHOTODYNAMIC THERAPY | Miravant Pharmaceuticals, Inc. (US) | 2004-09-01 | — | — | EP | disclosed |
| WO-2003028629-A2 | CHLORIN PHOTOSENSITIZING AGENTS FOR USE IN PHOTODYNAMIC THERAPY | MIRAVANT PHARMACEUTICALS, INC. (US) | 2003-04-10 | — | — | WO | disclosed |
| EP-0790986-B1 | ANILINE DERIVATIVES | ZENECA LTD (GB) | 1999-01-20 | — | — | EP | disclosed |
| EP-0790986-A1 | ANILINE DERIVATIVES | ZENECA LIMITED (GB) | 1997-08-27 | — | — | EP | disclosed |
| WO-1996015118-A1 | ANILINE DERIVATIVES | ZENECA LIMITED (GB) | 1996-05-23 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20050020559-A1 | Chlorin photosensitizing agents for use in photodynamic therapy | VHL, CRY1, PHLPP1 | CHRM2 4286/4885PIK3CD 653/4885MEN1 726/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.